Phase 2 Study of SAR439859 Versus Physician's Choice in Premenopausal and Postmenopausal Locally Advanced or Metastatic ER-positive Breast Cancer
Condition: Breast Cancer Metastatic Interventions: Drug: SAR439859; Drug: Endocrine monotherapy as per physician choice Sponsor: Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials